Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Applied Health Economics and Health Policy
|
December 7, 2019
Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT<sup>®</sup> Re-usable Inhaler
Gustaf Ortsäter, Fredrik Borgström, Mike Baldwin, et al.
The Patient
|
July 20, 2011
Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond
Mike Baldwin, Andrew Spong, Lynda Doward, et al.
Frontiers in Medicine
|
February 18, 2022
The Burden of Progressive-Fibrosing Interstitial Lung Diseases
Vincent Cottin, Rhiannon Teague, Lindsay Nicholson, et al.
IEEE Transactions on Visualization and Computer Graphics
|
November 4, 2006
An atmospheric visual analysis and exploration system
Yuyan Song, Jing Ye, Nikolai Svakhine, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 30, 2016
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
Oskar Eklund, Faraz Afzal, Fredrik Borgström, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Applied Health Economics and Health Policy
|
December 7, 2019
Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT<sup>®</sup> Re-usable Inhaler
Gustaf Ortsäter, Fredrik Borgström, Mike Baldwin, et al.
The Patient
|
July 20, 2011
Patient-reported outcomes, patient-reported information: from randomized controlled trials to the social web and beyond
Mike Baldwin, Andrew Spong, Lynda Doward, et al.
Frontiers in Medicine
|
February 18, 2022
The Burden of Progressive-Fibrosing Interstitial Lung Diseases
Vincent Cottin, Rhiannon Teague, Lindsay Nicholson, et al.
IEEE Transactions on Visualization and Computer Graphics
|
November 4, 2006
An atmospheric visual analysis and exploration system
Yuyan Song, Jing Ye, Nikolai Svakhine, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
June 30, 2016
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK
Oskar Eklund, Faraz Afzal, Fredrik Borgström, et al.
Page
of 1